Angiomyolipoma of the Kidney Symptoms

Angiomyolipoma of the kidney is a non-cancerous (benign) tumor made of fat, blood vessels, and smooth muscle cells. Many people with this condition do not experience any symptoms, especially if the tumors are small. When symptoms do appear, they are usually related to the tumor's size or if it bleeds, causing pain or other issues.

What is Angiomyolipoma of the Kidney?

An angiomyolipoma (AML) of the kidney is a non-cancerous growth that forms in one or both kidneys. These tumors are unique because they contain a mix of fat, blood vessels, and smooth muscle tissue. While they are not cancerous, larger AMLs can sometimes cause problems, such as pain or bleeding, which may require medical attention.

Angiomyolipomas are the most common benign (non-cancerous) tumors of the kidney. They are often discovered by chance during imaging tests done for other reasons. Most angiomyolipomas are small and do not grow very large. They are typically slow-growing and do not spread to other parts of the body. These tumors can occur as a single growth (sporadic) or as multiple growths in both kidneys. When multiple angiomyolipomas are present, especially in both kidneys, it is often linked to a genetic condition called tuberous sclerosis complex (TSC). Understanding the nature of these tumors helps in managing them effectively. While generally harmless, the main concern with angiomyolipomas is the risk of bleeding. The blood vessels within the tumor can be weak and prone to rupture, especially if the tumor is large. This bleeding can range from minor to severe, sometimes requiring emergency treatment.

Symptoms

Many people with an angiomyolipoma of the kidney do not have any symptoms, particularly if the tumor is small. When symptoms do occur, they often include pain in the side or back, blood in the urine, or a noticeable lump in the abdomen. These symptoms usually appear if the tumor grows large or if bleeding occurs.

The absence of symptoms is common, especially for angiomyolipomas that are less than 4 centimeters (about 1.5 inches) in size. This is why they are often found incidentally during scans for unrelated health issues. However, as the tumor grows, it can start to press on surrounding tissues or structures, leading to discomfort. If symptoms develop, the most common ones include pain in the flank (side of the body between the ribs and hip) or back. This pain can be dull and constant or sudden and severe if the tumor bleeds. Another symptom is blood in the urine (hematuria), which might be visible to the naked eye or only detectable through a lab test. Some individuals may also experience a feeling of fullness or a palpable mass in their abdomen. Less common symptoms can include high blood pressure (hypertension) or, in very rare cases, signs of kidney failure if the tumors are very large and affect a significant portion of both kidneys. The severity of symptoms often depends on the size of the tumor and whether it has bled. A sudden, severe pain in the side or back, especially if accompanied by dizziness or weakness, can indicate significant bleeding and requires immediate medical attention.

Causes & risk factors

The exact cause of most kidney angiomyolipomas is unknown, but they often occur sporadically, meaning they appear without a clear genetic link. However, a significant risk factor for developing multiple or larger angiomyolipomas, especially in both kidneys, is a genetic condition called tuberous sclerosis complex (TSC).

Most angiomyolipomas are sporadic, meaning they develop without an inherited cause and are not passed down through families. These sporadic cases account for about 80% of all kidney angiomyolipomas. They tend to occur more often in women and are usually found in only one kidney as a single tumor. The remaining 20% of angiomyolipomas are associated with tuberous sclerosis complex (TSC). TSC is a rare genetic disorder that causes non-cancerous tumors to grow in various organs, including the brain, skin, heart, lungs, and kidneys. People with TSC often develop multiple angiomyolipomas in both kidneys, and these tumors tend to be larger and more prone to bleeding. Another less common genetic condition, lymphangioleiomyomatosis (LAM), can also be associated with angiomyolipomas. While the precise mechanisms that trigger the growth of these tumors are still being researched, the genetic mutations linked to TSC (TSC1 or TSC2 genes) play a crucial role in regulating cell growth and division, and their dysfunction can lead to tumor formation.

How it's diagnosed

Angiomyolipomas of the kidney are typically diagnosed using imaging tests that can clearly show the characteristic fat content within the tumor. Common diagnostic tools include ultrasound, computed tomography (CT) scans, and magnetic resonance imaging (MRI). These tests help doctors confirm the diagnosis and assess the tumor's size and location.

The presence of fat within the tumor is a key feature that helps distinguish angiomyolipomas from other kidney masses, including cancerous ones. An ultrasound is often the first imaging test performed because it is non-invasive and readily available. It can identify a mass and sometimes suggest its fatty nature. For a more definitive diagnosis, a computed tomography (CT) scan or magnetic resonance imaging (MRI) is usually performed. CT scans are particularly good at detecting the fat component, which appears distinctively dark on the images. MRI can also clearly show the fat and provide detailed information about the tumor's relationship to surrounding kidney tissue and blood vessels. In most cases, if the imaging tests clearly show the characteristic fat content, a biopsy (taking a tissue sample for examination) is not needed. However, if the imaging results are unclear or if the tumor does not contain much fat (known as a fat-poor angiomyolipoma), a biopsy might be considered to rule out other types of kidney tumors, including kidney cancer.

Treatment options

Treatment for kidney angiomyolipomas depends on the tumor's size, whether it is causing symptoms, and its risk of bleeding. Small, asymptomatic tumors often require only watchful waiting. Larger or symptomatic tumors may be treated with medication, a procedure to block blood flow (embolization), or surgery to remove part or all of the kidney.

For most small angiomyolipomas (typically less than 4 cm or 1.5 inches) that are not causing any symptoms, doctors usually recommend a 'watchful waiting' approach. This involves regular follow-up imaging tests, such as ultrasound or CT scans, to monitor the tumor's size and growth over time. The goal is to ensure the tumor remains stable and does not pose a risk. If an angiomyolipoma is large (often greater than 4 cm) or is causing symptoms like pain or bleeding, more active treatment may be necessary. One common treatment is selective arterial embolization. This procedure involves injecting a substance into the blood vessels that supply the tumor, blocking blood flow and causing the tumor to shrink. This can effectively stop bleeding and reduce tumor size. Surgery may be considered for very large tumors, those that have bled severely, or when embolization is not effective. Kidney-sparing surgery (partial nephrectomy), which removes only the tumor and a small amount of surrounding tissue, is often preferred to preserve kidney function. In some cases, especially for individuals with tuberous sclerosis complex, medications called mTOR inhibitors (e.g., everolimus) can be used to shrink angiomyolipomas and reduce the risk of bleeding. These medications work by targeting specific pathways involved in cell growth.

Recovery & outlook

The outlook for people with kidney angiomyolipomas is generally very good, as these tumors are non-cancerous and usually do not cause serious health problems. Most individuals live normal lives, especially if their tumors are small and managed with watchful waiting. Even with treatment, recovery is often straightforward, with a focus on preventing complications like bleeding.

For the majority of people with small, asymptomatic angiomyolipomas, the condition has little impact on their overall health or life expectancy. Regular monitoring helps ensure that any changes are caught early. If a tumor grows or becomes symptomatic, effective treatments are available to manage it. Recovery after procedures like embolization or partial nephrectomy is typically good. Patients may experience some pain or discomfort initially, but this usually resolves within a few weeks. Long-term follow-up is important to monitor for any recurrence or the development of new tumors, particularly for those with tuberous sclerosis complex. While the risk of severe bleeding is the main concern, it is relatively rare, especially for smaller tumors. With appropriate medical care and monitoring, the vast majority of individuals with kidney angiomyolipomas can expect a positive long-term outlook. It is crucial to maintain open communication with your healthcare provider about any new symptoms or concerns.

When to see a doctor

You should see a doctor if you experience any new or worsening symptoms that might be related to a kidney angiomyolipoma, such as persistent pain in your side or back, or blood in your urine. Seek immediate medical attention if you have sudden, severe pain in your side or back, especially if accompanied by dizziness, weakness, or rapid heart rate, as these could be signs of significant bleeding.

If you have been diagnosed with an angiomyolipoma, it is important to follow your doctor's recommendations for regular check-ups and imaging. Report any changes in your health promptly. Even if your tumor is small and currently asymptomatic, new symptoms can develop over time. Specific signs that warrant a doctor's visit include any unexplained pain in your flank or back that does not go away, or if you notice your urine appears pink, red, or brown due to blood. A noticeable lump in your abdomen or unexplained high blood pressure should also be discussed with your healthcare provider. Emergency signs that require immediate medical attention include sudden, intense pain in your side or back, which could indicate a ruptured angiomyolipoma and internal bleeding. Other emergency symptoms include feeling lightheaded, dizzy, unusually weak, or experiencing a rapid heartbeat. These symptoms suggest a significant loss of blood and require urgent medical care.

Frequently asked questions

Can an angiomyolipoma turn into cancer?

No, an angiomyolipoma is a non-cancerous (benign) tumor and does not turn into cancer. It is made of fat, blood vessels, and muscle cells, which are different from cancerous cells. However, it's important to distinguish it from other kidney masses that could be cancerous, which is why imaging tests are crucial for diagnosis.

How fast do kidney angiomyolipomas grow?

The growth rate of kidney angiomyolipomas can vary. Many grow very slowly or not at all, especially smaller ones. Larger tumors, or those associated with tuberous sclerosis complex, may grow more quickly. Regular imaging helps doctors monitor their size and growth over time.

What is the main risk of having an angiomyolipoma?

The main risk associated with an angiomyolipoma is bleeding. The blood vessels within the tumor can be weak and prone to rupture, especially if the tumor is large (typically over 4 cm). This bleeding can cause pain and, in severe cases, lead to significant blood loss requiring emergency treatment.

Can diet or lifestyle changes affect angiomyolipomas?

There is no scientific evidence to suggest that specific diet or lifestyle changes can prevent the formation or alter the growth of angiomyolipomas. However, maintaining a healthy lifestyle is always beneficial for overall kidney health and general well-being.

Are angiomyolipomas hereditary?

Most angiomyolipomas are sporadic, meaning they are not inherited. However, about 20% are associated with tuberous sclerosis complex (TSC), a genetic condition that can be inherited. If you have multiple angiomyolipomas or a family history of TSC, genetic counseling may be recommended.

What is the difference between a sporadic angiomyolipoma and one associated with TSC?

Sporadic angiomyolipomas usually occur as a single tumor in one kidney and are more common in women. Angiomyolipomas associated with tuberous sclerosis complex (TSC) often involve multiple tumors in both kidneys, tend to be larger, and are more prone to complications like bleeding. TSC is a genetic condition, while sporadic cases are not inherited.

Sources

• MedlinePlus — Angiomyolipoma of the Kidney Symptoms
• Mayo Clinic — Angiomyolipoma of the Kidney Symptoms
• Cochrane Library — Angiomyolipoma of the Kidney Symptoms